Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)

被引:39
|
作者
Nier, Anika [1 ]
Huber, Yvonne [2 ]
Labenz, Christian [2 ]
Michel, Maurice [2 ]
Bergheim, Ina [1 ]
Schattenberg, Joern M. [2 ]
机构
[1] Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, A-1090 Vienna, Austria
[2] Johannes Gutenberg Univ Mainz, Dept Med 1, Metab Liver Res Program, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany
关键词
non-alcoholic fatty liver disease; dietary fiber consumption; bacterial endotoxin; hepatic fibrosis; GUT MICROBIOTA; FIBROSIS; STEATOHEPATITIS; PATHOGENESIS; IMPACT; RISK;
D O I
10.3390/nu12030699
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
(1) Background: The etiology of non-alcoholic fatty liver disease (NAFLD) is multifactorial. Dietary composition has been implicated as a factor modulating intestinal barrier and could affect disease severity. The aim of this study was to evaluate dietary intake and markers of intestinal permeability in patients with NAFLD. (2) Methods: We enrolled 63 patients with NAFLD and compared them to age-matched controls. (3) Results: body mass index (BMI) and leptin to adiponectin ratio-the latter being an indicator of abdominal fat accumulation-correlated with the degree of hepatic steatosis being accompanied with rising levels of fasting insulin. Furthermore, endotoxin plasma levels and markers of inflammation were significantly higher in NAFLD compared to controls and increased with the severity of hepatic steatosis. Despite comparable intake of total energy and macronutrients, intake of fiber was lower in all patients with NAFLD compared to controls and were negatively related to disease severity. (4) Conclusions: Taken together, results of the present study suggest that fiber intake in patients is negatively related to steatosis degree and bacterial endotoxin levels, further suggesting that dietary fiber intake may be a target in NAFLD treatment (NCT: 02366052 and 03482284).
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Hepatic manifestation of metabolic syndrome (MS): Non-alcoholic fatty liver disease (NAFLD) and serum adipokines
    Jarrar, M.
    Ranard, B.
    Stepanova, M.
    Nugent, C.
    Elariny, H.
    Bennett, C.
    Collantes, R.
    Goodman, Z.
    Chandhoke, V.
    Baranova, A.
    Younossi, Z.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S271 - S271
  • [2] Controlled Attenuation Parameter (CAP) for the detection of hepatic steatosis in alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD)
    Naveau, Sylvie
    Perlemuter, Gabriel
    Ziol, Marianne
    Carmona, Damien
    Trinchet, Jean Claude
    Prevot, Sophie
    Nohra, Pascal
    Nguefang-Njike, Micheline Nakseu
    Beaugrand, Michel
    [J]. HEPATOLOGY, 2012, 56 : 898A - 898A
  • [3] Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease
    Kojic, N. Eremic
    [J]. CLINICA CHIMICA ACTA, 2019, 493 : S362 - S362
  • [4] Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease
    Eremic-Kojic, N.
    Deric, M.
    Govorcin, M. L.
    Balac, D.
    Kresoja, M.
    Kojic-Damjanov, S.
    [J]. HIPPOKRATIA, 2018, 22 (01) : 10 - 16
  • [5] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
  • [6] Pancreatic Steatosis Does Not Correlate With Severity of Non-Alcoholic Fatty Liver Disease (NAFLD) on Magnetic Resonance Imaging (MRI)
    Pinion, L.
    Davarpanah, A. H.
    Reshamwala, P.
    Patel, V.
    Keilin, S.
    Willingham, F.
    Chawla, S.
    [J]. PANCREAS, 2021, 50 (07) : 1090 - 1090
  • [7] Adipokines and cytokines in non-alcoholic fatty liver disease
    Tasci, I.
    Dogru, T.
    Ercin, C. N.
    Erdem, G.
    Sonmez, A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (02) : 266 - 267
  • [8] miR-101 IN STEATOSIS AND STEATOHEPATITIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Elfimova, N.
    Ommer, K.
    Schlattjan, M.
    Sowa, J. P.
    Wedemeyer, I.
    Vantler, M.
    Dienes, H. P.
    Canbay, A.
    Odenthal, M.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S508 - S508
  • [9] Adipokines and cytokines in non-alcoholic fatty liver disease
    Jarrar, M. H.
    Baranova, A.
    Collantes, R.
    Ranard, B.
    Stepanova, M.
    Bennett, C.
    Fang, Y.
    Elariny, H.
    Goodman, Z.
    Chandhoke, V.
    Younossi, Z. M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (05) : 412 - 421
  • [10] Biomarkers identifying hepatic inflammation in non-alcoholic fatty liver disease (NAFLD)
    Werge, Mikkel
    Hoegl, Annabelle
    Therkelsen, Marie Louise
    Gronborg, Mads
    Mazzoni, Gianluca
    Harder, Lea Morch
    Hvid, Henning
    Rashu, Elias
    Thing, Mira
    Hetland, Liv
    Junker, Anders
    Serizawa, Reza
    Vyberg, Mogens
    Galsgaard, Elisabeth
    Gluud, Lise Lotte
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S742 - S743